Nacionalinis vėžio institutas (National Cancer Institute) is the sole specialized cancer treatment and research institution in Lithuania, with a history dating back to 1931. Formerly known as the Institute of Oncology Vilnius University, it was rebranded as the National Cancer Institute in 2014. The NCI's mission extends to conducting international research in oncology, aiming to enhance cancer treatment effectiveness, reduce mortality rates, and fosters the training of scientists and highly skilled specialists. Additionally, the institute seeks to reinforce Lithuania's scientific potential and competitiveness in the European Research Area. As a Health Care entity, it holds strategic importance in contributing to the advancements in cancer treatment, research, and the development of skilled professionals in the field. Despite the absence of recent investment data, the NCI's dedication to comprehensive cancer research and treatment positions it as a significant player in the global battle against cancer. Based in Lithuania, the NCI presents a compelling opportunity for potential investors looking to contribute to the advancement of cancer care and research.
There is no investment information
No recent news or press coverage available for Nacionalinis vėžio institutas / National Cancer Institute.